https://orcid.org/0000-0001-8070-5323
References
- Department of Health and Human Services. Office of the Inspector General. Changes made to state’s Medicaid programs to ensure beneficiary access to prescriptions during the COVID-19 pandemic; 2020. Available from: https://oig.hhs.gov/oas/reports/region6/62004007.pdf. Accessed: January 28, 2023.
- Czeisler MÉ, Marynak K, Clarke KEN, et al. Delay or avoidance of medical care because of COVID-19-related concerns—United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250–1257. doi:10.15585/mmwr.mm6936a4
- Centers for Medicaid and Medicare. National Medicaid Fee-For-Service (FFS), FFY 2020 Drug Utilization Review (DUR) Annual Report. Available from: https://www.medicaid.gov/medicaid/prescription-drugs/downloads/2020-dur-ffs-summary-report.pdf. Accessed January 30, 2023.
- Alexander GC, Stoller KB, Haffajee RL, Saloner B. An epidemic in the midst of a pandemic: opioid use disorder and COVID-19. Ann Intern Med. 2020;173(1):57–58. doi:10.7326/M20-1141
- O’Donnell J, Gladden RM, Mattson CL, et al. Vital signs: characteristics of drug overdose deaths involving opioids and stimulants — 24 States and the District of Columbia, January–June 2019. MMWR Morb Mortal Wkly Rep. 2020;69(35):1189–1197. doi:10.15585/mmwr.mm6935a1
- Colorado Department of Health Care Policy and Financing: pain management resources and opioid use; 2023. Available from: https://hcpf.colorado.gov/pain-management-resources-and-opioid-use. Accessed January 28, 2023.
- Anderson HD, Patterson V, Wright G, et al. Evaluation of an opioid pain teleconsultation service to address the opioid overdose epidemic in Colorado: a Health First Colorado demonstration project. J Am Pharm Assoc. 2023;63(1):301–308. doi:10.1016/j.japh.2022.11.009
- Auty SG, Griffith KN. Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2022;232:109340. doi:10.1016/j.drugalcdep.2022.109340
- Friedman JR, Hansen H. Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry. 2022;79(4):379–381. doi:10.1001/jamapsychiatry.2022.0004
- Slavova S, Rock P, Bush HM, et al. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176. doi:10.1016/j.drugalcdep.2020.108176
- Center for Disease Control. Center for Preparedness and Response. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. Center for Disease Control and Prevention; 2020. Available from: https://emergency.cdc.gov/han/2020/han00438.asp. Accessed January 28, 2023.
- Burgess-Hull AJ, Smith KE, Panlilio LV, et al. Nonfatal opioid overdoses before and after COVID-19: regional variation in rates of change. PLoS One. 2022;17(3):e0263893. doi:10.1371/journal.pone.0263893
- Rikin S, Perez HR, Zhan C, et al. Changes in outpatient opioid prescribing during the COVID-19 pandemic: an interrupted time series analysis. J Prim Care Commun Health. 2022;13:1–6. doi:10.1177/21501319221076926
- IQVIA. IQVIA PharMetrics plus for academics users guide & data dictionary; 2017.
- Wagner AK, Soumerai SB, Zhang F, et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309. doi:10.1046/j.1365-2710.2002.00430
- Jenkins RA. The fourth wave of the US opioid epidemic and its implications for rural US: a federal perspective. Prev Med. 2021;152(Pt 2):106541. doi:10.1016/j.ypmed.2021.106541
- Colorado Health Institute. A parallel epidemic: more overdose deaths more overdose deaths in 2020, fentanyl fatalities spike; 2022. Available from: https://www.coloradohealthinstitute.org/research/2020overdose_dashboard. Accessed January 28, 2023.